Table 3.
Univariable and multivariable associations in four evidence-based drug classes (ATC code)
Antithrombotics (B01) | Lipid-lowering (C10) | Thyroid meds (H03) | Respiratory inhalers (R03) | |||||
Unadjusted OR (95% CI, p value) | Adjusted OR (95% CI, p value) | Unadjusted OR (95% CI, p value) | Adjusted OR (95% CI, p value) | Unadjusted OR (95% CI, p value) | Adjusted OR (95% CI, p value) | Unadjusted OR (95% CI, p value) | Adjusted OR (95% CI, p value) | |
Hospitalised vs non-hospitalised | 0.95 (0.82 to 1.10), p=0.49 | 0.95 (0.81 to 1.11), p=0.49 | 1.04 (0.89 to 1.20), p=0.64 | 0.92 (0.78 to 1.08), p=0.29 | 0.68 (0.46 to 1.00), p=0.05 | 0.62 (0.40 to 0.96), p=0.03 | 0.62 (0.49 to 0.78), p=0.001 | 0.63 (0.49 to 0.80), p<0.001 |
Age (years) | 1.02 (1.01 to 1.03), p<0.001 | 1.03 (1.02 to 1.04), p<0.001 | 1.04 (1.03 to 1.05), p<0.001 | 1.05 (1.04 to 1.06), p<0.001 |
1.03 (1.01 to 1.05), p=0.002 | 1.06 (1.04 to 1.09), p<0.001 | 1.02 (1.01 to 1.03), p=0.004 | 1.04 (1.02 to 1.05), p<0.001 |
Gender Female vs male |
1.02 (0.89 to 1.17), p=0.79 | 1.00 (0.87 to 1.15), p=0.99 | 0.85 (0.74 to 0.96), p=0.01 | 0.82 (0.72 to 0.95), p=0.01 | 0.84 (0.57 to 1.24), p=0.38 | 0.85 (0.56 to 1.30), p=0.46 | 1.04 (0.85 to 1.28), p=0.68 | 1.03 (0.83 to 1.27), p=0.79 |
Insurance type Private vs GMS/DVC patients | 5.10 (4.31 to 6.04), p<0.001 | 5.35 (4.50 to 6.34), p<0.001 | 4.78 (4.06 to 5.62), p<0.001 | 5.68 (4.48 to 6.73), p<0.001 | 9.79 (6.90 to 13.89), p<0.001 | 11.67 (8.02 to 16.96), p<0.001 | 3.66 (2.78 to 4.82), p<0.001 | 3.75 (2.84 to 4.96), p<0.001 |
Number of repeat drug classes | 0.99 (0.98 to 1.01), p=0.56 | 0.99 (0.97 to 1.01), p=0.28 | 1.01 (1.00 to 1.04), p=0.04 | 1.01 (0.99 to 1.04), p=0.24 | 0.98 (0.95 to 1.02), p=0.41 | 0.98 (0.94 to 1.03), p=0.44 | 0.97 (0.94 to 0.99), p=0.01 | 0.97 (0.94 to 0.99), p=0.02 |
Charlson score (≥1 vs 0) |
0.93 (0.80 to 1.07), p=0.31 | 0.94 (0.80 to 1.09), p=0.41 | 1.05 (0.91 to 1.21), p=0.48 | 0.98 (0.84 to 1.14), p=0.78 | 0.78 (0.56 to 1.08), p=0.15 | 0.80 (0.54 to 1.15), p=0.22 | 0.66 (0.53 to 0.81), p<0.001 | 0.71 (0.58 to 0.88), p=0.002 |
No of consultations in enrolment period | 1.00 (0.99 to 1.01), p=0.62 | 1.00 (0.99 to 1.01), p=0.63 | 1.00 (0.99 to 1.01), p=0.69 | 1.00 (0.99 to 1.01), p=0.75 | 0.99 (0.97 to 1.00), p=0.11 | 1.00 (0.98 to 1.02), p=0.83 | 0.99 (0.98 to 1.00), p=0.02 | 1.00 (0.99 to 1.01), p=0.72 |
Adjusted model includes gender, age, insurance type, Charlson Index, number of repeat drugs, number of consultations in the enrolment period.
ATC, Anatomical Therapeutic Chemical classification system; GMS, general medical services; DVC, doctor visit card.